Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pomper

Showing results (351-360 of 525) with videos related to

Pageof 53
Sort By:
Angewandte Chemie (International Ed. in English)|October 21, 2016
Cathepsin B-Specific Metabolic Precursor for In Vivo Tumor-Specific Fluorescence ImagingMan Kyu Shim, Hong Yeol Yoon, Ju Hee Ryu, et al.
Molecular Imaging|January 7, 2009
Detection of dose response in chronic doxorubicin-mediated cell death with cardiac technetium 99m annexin V single-photon emission computed tomographyKathleen L Gabrielson, Greta S P Mok, Srihdar Nimmagadda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Directed Radioligand TherapyPhilipp E Hartrampf, Patrick W Mihatsch, Anna Katharina Seitz, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 28, 2015
Prostate-specific membrane antigen as a target for cancer imaging and therapyA P Kiess, S R Banerjee, R C Mease, et al.
Theranostics|March 21, 2020
Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancerColette J Shen, Il Minn, Robert F Hobbs, et al.
Scientific Reports|May 16, 2025
A pilot study of PSMA-targeted F-18-DCFPyL PET imaging of patients with adenoid cystic carcinomaAndrew F Voter, Alireza Amindarolzarbi, Colette J Shen, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 7, 2018
Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate CancerSangeeta Ray Banerjee, Xiaolei Song, Xing Yang, et al.
Biological Psychiatry|April 15, 2018
Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant DataPontus Plavén-Sigray, Granville J Matheson, Karin Collste, et al.
Journal of Medicinal Chemistry|February 26, 2020
Novel β- and γ-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane AntigenKyul Kim, Hongmok Kwon, Cyril Barinka, et al.
Journal of Medicinal Chemistry|December 3, 2015
[(18)F]Fluorobenzoyllysinepentanedioic Acid Carbamates: New Scaffolds for Positron Emission Tomography (PET) Imaging of Prostate-Specific Membrane Antigen (PSMA)Xing Yang, Ronnie C Mease, Mrudula Pullambhatla, et al.
Pageof 53

Showing results (351-360 of 525) with videos related to

Sort By:
Pageof 53
Angewandte Chemie (International Ed. in English)|October 21, 2016
Cathepsin B-Specific Metabolic Precursor for In Vivo Tumor-Specific Fluorescence ImagingMan Kyu Shim, Hong Yeol Yoon, Ju Hee Ryu, et al.
Molecular Imaging|January 7, 2009
Detection of dose response in chronic doxorubicin-mediated cell death with cardiac technetium 99m annexin V single-photon emission computed tomographyKathleen L Gabrielson, Greta S P Mok, Srihdar Nimmagadda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Directed Radioligand TherapyPhilipp E Hartrampf, Patrick W Mihatsch, Anna Katharina Seitz, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 28, 2015
Prostate-specific membrane antigen as a target for cancer imaging and therapyA P Kiess, S R Banerjee, R C Mease, et al.
Theranostics|March 21, 2020
Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancerColette J Shen, Il Minn, Robert F Hobbs, et al.
Scientific Reports|May 16, 2025
A pilot study of PSMA-targeted F-18-DCFPyL PET imaging of patients with adenoid cystic carcinomaAndrew F Voter, Alireza Amindarolzarbi, Colette J Shen, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 7, 2018
Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate CancerSangeeta Ray Banerjee, Xiaolei Song, Xing Yang, et al.
Biological Psychiatry|April 15, 2018
Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant DataPontus Plavén-Sigray, Granville J Matheson, Karin Collste, et al.
Journal of Medicinal Chemistry|February 26, 2020
Novel β- and γ-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane AntigenKyul Kim, Hongmok Kwon, Cyril Barinka, et al.
Journal of Medicinal Chemistry|December 3, 2015
[(18)F]Fluorobenzoyllysinepentanedioic Acid Carbamates: New Scaffolds for Positron Emission Tomography (PET) Imaging of Prostate-Specific Membrane Antigen (PSMA)Xing Yang, Ronnie C Mease, Mrudula Pullambhatla, et al.
Pageof 53